Furthermore, these results revealed the potential mechanism of OMV accumulation in tumor tissue and production of IFN-γ within the tumor microenvironment to activate antitumor response and expanded the application of OMVs as cancer vaccines not only as delivery platforms but also as antitumor agents. This evidence concerns the gene IFNG and neoplasm.